NFKB1 and Hyperglycemia: It has been suggested that overexpression of miRNA 146a in diabetic patients may represent a protective defense mechanism by the body against inflammation by downregulating TNF-α and other target genes of the NF-κB pathway; thus, protect the body against the complications caused by hyperglycemia [40].